eagle-i University of Hawaii at ManoaUniversity of Hawaii at Manoa
See it in Search
This page is a preview of the following resource. Continue onto eagle-i search using the button on the right to see the full record.

Program for the Assessment of Clinical Cancer Tests (PACCT-1): Trial Assigning Individualized Options for Treatment: the TAILORx trial

eagle-i ID


Resource Type

  1. Clinical trial


  1. ClinicalTrials.gov url
  2. Intervention
  3. Intervention
  4. Intervention
  5. Intervention
    Tamoxifen citrate
  6. Additional Topic(s)
    Combined antineoplastic chemotherapy
  7. Additional Topic(s)
    Hormone therapy
  8. Additional Topic(s)
    Oncotype DX
  9. Resource Description
    New tests may provide information about which patients are more likely to benefit from chemotherapy. This randomized phase III trial is trying to find out the best individual therapy for women who have node-negative, estrogen-receptor positive breast cancer by using a special test (Oncotype DX), and whether hormone therapy alone or hormone therapy together with combination chemotherapy is better for women who have an Oncotype DX recurrence score of 11-25.
  10. Contact
    Berenberg, Jeffrey
  11. PI
    Berenberg, Jeffrey
  12. Topic
    breast cancer
  13. Study Population
    Women 18 to 75 years with histologically confirmed adenocarcinoma of the breast
  14. Funded by
    Cancer Trials Support Unit
  15. Phase
    Phase 3 clinical trial
  16. Performed by
    Clinical Protocol & Data Management Shared Resource
Provenance Metadata About This Resource Record
Copyright © 2016 by the President and Fellows of Harvard College
The eagle-i Consortium is supported by NIH Grant #5U24RR029825-02 / Copyright 2016